An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD-Reference-Cited by-同舟云学术

An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD

Published:2021-12 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Lim Grace En Hui,Tang Ansel,Ng Cheng Han,Chin Yip Han,Lim Wen Hui,Tan Darren Jun Hao,Yong Jie Ning,Xiao Jieling,Lee Chloe Wen-Min,Chan Mark,Chew Nicholas WS.,Xuan Tan Eunice Xiang,Siddiqui Mohammad Shadab,Huang Daniel,Noureddin Mazen,Sanyal Arun J.,Muthiah Mark D.^ORCID

Funder

Bristol-Myers Squibb

Gilead Sciences

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference62 articles.

1. Non-alcoholic fatty liver disease;Powell;Lancet,2021

2. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

3. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

4. A clinical overview of NAFLD: a guide to diagnosis, the clinical features, and complications – what the non-specialist needs to know;Muthiah;Diabetes Obes Metab,2021

5. Nonalcoholic steatohepatitis: a review;Sheka;JAMA,2020

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Piperlongumine, a natural alkaloid from Piper longum L. ameliorates metabolic-associated fatty liver disease by antagonizing the thromboxane A2 receptor;Biochemical Pharmacology;2024-11

2. Effectiveness of mobile health intervention for non alcoholic fatty liver disease- A meta analysis of randomized controlled trials;Clinics and Research in Hepatology and Gastroenterology;2024-10

3. High-density lipoprotein cholesterol trajectory and new-onset metabolic dysfunction-associated fatty liver disease incidence: a longitudinal study;Diabetology & Metabolic Syndrome;2024-09-11

4. Associations of exposure to perchlorate, thiocyanate, and nitrate with metabolic dysfunction–associated steatotic liver disease: Evidence from a population-based cross-sectional study in the United States;Journal of Cleaner Production;2024-09

5. A Case–Control Study Supports Genetic Contribution of the PON Gene Family in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease;Antioxidants;2024-08-29